The potential association between elevated prolactin levels and human breast cancer has been a topic of interest ever since studies in rodents demonstrated a causal relationship between prolactin and initiation and growth of tumors in the 1970s (3), and evidence collected in the subsequent decades has been well summarized (4). This evidence concerns the gene PRL and breast carcinoma.